8.52 USD
↘ 0.06 (0.72%)PRE MARKET (AS OF 07:01 AM EDT)
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOTNASDAQ • USD
Market: OPEN
Open?$8.21
High?$8.45
Low?$8.21
Prev. Close?$8.51
Volume?N/A
Avg. Volume?457.4K
Bid / Ask
Bid?$6.92 × 100
Ask?$10.61 × 100
Spread?$3.69
Midpoint?$8.77
Valuation & Ratios
Market Cap?681.7M
Shares Out?80.1M
Float?42.4M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?1.83
EPS?-$1.56
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Employees
92
Market Cap
681.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-08-12
Address
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.16Strong
Quick Ratio?6.16Strong
Cash Ratio?1.22Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?1.83CHEAP▾
P/S?588,189.35HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.5CHEAP▾
EV/Sales?543,373.13HIGH▾
Returns & Efficiency
ROE?-33.5%WEAK▾
ROA?-29.9%WEAK▾
Cash Flow & Enterprise
FCF?$-149706358
Enterprise Value?$629.8M
Fundamentals ratios updated end of day